| Specifications | |
|---|---|
| Product type | mRNA |
| Modified bases | Pseudo-UTP |
| 5' Cap | Cap 1 |
| Species | Human |
| RefSeq | NM_019004.2 |
| Applications | Gene therapy research |
| Format | Powder |
| Quantity | 100 µg |
| Purification | Chromatography |
| Target Gene | |
|---|---|
| Gene ID | 54467 |
| UniProt ID | Q9P2G1 |
| Specifications | |
|---|---|
| Product type | mRNA |
| Modified bases | Pseudo-UTP |
| 5' Cap | Cap 1 |
| Species | Human |
| RefSeq | NM_019004.2 |
| Applications | Gene therapy research |
| Format | Powder |
| Quantity | 100 µg |
| Purification | Chromatography |
| Target Gene | |
|---|---|
| Gene ID | 54467 |
| UniProt ID | Q9P2G1 |
| Download |
|---|
| Download resources about mRNA therapeutics development to boost your research. |
| CUSTOMER REVIEWS and Q&As | |
|---|---|
|
There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human ANKIB1, (Cap 1, Pseudo-UTP, 120 nt-poly(A)) (GTTS-WK18190MR). Click the button above to contact us or submit your feedback about this product. |
|
| See other products | |||
|---|---|---|---|
| CAT | Product Name | Product Type | CDs |
| GTTS-WK6694MR | IVTScrip™ mRNA-Human CD13, (Cap 1, 5-Methyl-CTP, 30 nt-poly(A)) | mRNA | CD13 |
| GTTS-WK22151MR | IVTScrip™ mRNA-Human ATG10, (Cap 0, N1-Methylpseudo-UTP, 120 nt-poly(A)) | mRNA | ATG10 |
| GTTS-WK1640MR | IVTScrip™ mRNA-Human CRYL1, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) | mRNA | CRYL1 |
| GTTS-WK14281MR | IVTScrip™ mRNA-Human ACY3, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) | mRNA | ACY3 |
| GTTS-WK22990MR | IVTScrip™ mRNA-Human ASAH1, (Cap 0, 5-Methyl-CTP, 120 nt-poly(A)) | mRNA | ASAH1 |
| GTTS-WK11325MR | IVTScrip™ mRNA-Human ADCYAP1, (Cap 1, N1-Methylpseudo-UTP, 120 nt-poly(A)) | mRNA | ADCYAP1 |
| GTTS-WK17222MR | IVTScrip™ mRNA-Human Alkaline phosphatase, (Cap 0, 2-Thio-UTP, 30 nt-poly(A)) | mRNA | Alkaline phosphatase |
| GTTS-WK11021MR | IVTScrip™ mRNA-Human ADCY5, (Cap 1, Pseudo-UTP, 120 nt-poly(A)) | mRNA | ADCY5 |